Company Filing History:
Years Active: 2014
Title: Lee H Bouwman: Innovator in Complement System Diagnostics
Introduction
Lee H Bouwman is a notable inventor based in PZ Leiden, Netherlands. He has made significant contributions to the field of diagnostics, particularly in understanding the complement system's lectin pathway. His innovative work has led to the development of a unique assay that addresses deficiencies in this critical immune pathway.
Latest Patents
Bouwman holds a patent for the "Lectin pathway deficiency assay." This invention refers to an in vitro method for functionally determining deficiencies in the lectin pathway of the complement system under physiological conditions. The method involves several steps, including providing a sample of mammalian blood or other body fluids, preventing the activation of the classical and alternative pathways, activating the lectin pathway, and determining any activation of the autologous C5b-9 complex. Additionally, the invention includes a kit designed for functionally determining deficiencies in the lectin pathway, which comprises an inert carrier, a substance activating the lectin pathway, a diluent with an inhibitor of the C1 complex, and an antibody against the autologous C5b-9 complex.
Career Highlights
Bouwman is associated with Euro-Diagnostica AB, a company that focuses on developing diagnostic solutions. His work has been instrumental in advancing the understanding of the complement system and its implications in various diseases. With a patent portfolio that includes one patent, Bouwman continues to contribute to the field of immunology and diagnostics.
Collaborations
Some of his notable coworkers include Johanna Roos and Mohamed R Daha. Their collaborative efforts have further enhanced the research and development of diagnostic tools in the field.
Conclusion
Lee H Bouwman's innovative contributions to the field of diagnostics, particularly through his patent on the lectin pathway deficiency assay, highlight his role as a key figure in advancing medical science. His work continues to impact the understanding and diagnosis of immune system deficiencies.